跳至主要内容
临床试验/NCT06947148
NCT06947148已完成不适用

The Impact of Comprehensive Post Hospital Management Based on Digital Health Intervention on Cardiac Function in Patients With Heart Failure: a Prospective, Multicenter, Randomized Controlled Study

Harbin Medical University1 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2025年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
104
试验地点
1
主要终点
6-minute walk test

研究概览

简要总结

Due to the complex nature of HF patients' conditions, long-term treatment and management are required, especially post hospital management, which is of great significance for improving patients' cardiac function and quality of life. With the increasing popularity of smartphones and the continuous development of medical technology, digital health intervention (DHI) has emerged as a new medical model in the treatment of diseases.

This study will establish a comprehensive post hospital management model of HF based on DHI, including cognitive behavioral therapy, digital self-monitoring and remote dielectric sensing (ReDS™) technology, etc., comprehensively strengthen the post hospital intervention and management of HF. Objective to explore the effect of comprehensive post hospital management based on DHI on cardiac function of patients with HF 6 months after discharge.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients hospitalized for HF, NYHA classification II-IV upon admission
  • •The patient's residence is within the urban area of each center, and ReDS™ technology can be performed at home or at the outpatient clinic
  • •No difficulty using smartphones, with basic Chinese reading and writing skills
  • •Accept the terms and conditions of the study and obtain informed consent from the subjects/their families

排除标准

  • •Age<21 years old
  • •Patients with height<155 cm or>190 cm, BMI<22 kg/m2 or>36 kg/m2, chest circumference<80 cm or>115 cm, and flail chest or rib fractures
  • •History of pulmonary embolism
  • •chronic renal failure(Scr > 443umol/L)
  • •History of heart transplantation or pacemaker implantation
  • •Severe pulmonary hypertension
  • •Suffering from end-stage chronic obstructive pulmonary disease, requiring home oxygen therapy
  • •Massive pleural effusion
  • •The subject is unable to complete the 6-minute walking test
  • •Expected lifespan<6 months
  • •Researchers believe that participants are not suitable to participate in this trial (such as pregnancy, severe visual or hearing impairment, etc.)
  • •Individuals who are unable to understand and/or comply with this research procedure (such as those who are addicted to alcohol, substance abuse, or have mental illnesses)
  • •Currently participating in clinical trials of other devices or drugs
  • •Researchers involved in the design and execution of this study

研究组 & 干预措施

Routine Management Group

No Intervention

The routine management group will accept the routine HF management of SOC throughout the course, and the doctor will carry out treatment and management according to the actual clinical situation, including pre discharge education, precautions for commonly used drugs, guidance for daily life activities, etc.

Comprehensive post hospital management group

Other

Based on the routine HF management of standard of care (SOC), the intervention group will carry out comprehensive post hospital management based on DHI, including cognitive behavioral therapy, digital self-monitoring and ReDS™ technology, etc.

干预措施: Comprehensive post hospital management based on digital health intervention(DHI) (Other)

结局指标

主要结局

6-minute walk test

时间窗: The 6th month after discharge

Improvement in 6-minute walk test after discharge for 6 months

次要结局

  • Quality of life index (QLI) rating(The 1st ,3rd and 6th months after discharge)
  • Kansas city cardiomyopathy questionnaire (KCCQ-23) rating(The 1st ,3rd and 6th months after discharge)
  • NYHA classification(The 1st ,3rd and 6th months after discharge)
  • Left ventricular ejection fraction (LVEF)(The 6th month after discharge)
  • Number of readmissions for heart failure(Within 6 months after discharge)
  • All-cause mortality(Within 6 months after discharge)
  • Composite endpoint of all-cause death or readmission due to heart failure(Within 6 months after discharge)
  • Time to first hospitalization for heart failure from baseline(Within 6 months after discharge)
  • Cardiac death(Within 6 months after discharge)

研究者

发起方
Harbin Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yu Bo

Chief Physician

Harbin Medical University

研究点 (1)

Loading locations...

相似试验